In this study, we sought to investigate the role of Reg IV in comparison to P53 and KRAS in UC-associated dysplasia and CRC in order to evaluate the potential use of Reg IV for dysplasia and cancer screening in patients with long-standing UC. The gene discussed is TP53; the disease is cancer.